ReviewJCO global oncology2020
Breast Cancer Care in Jordan.
Review in JCO global oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05592938 (Partial Breast Re-irradiation Using Ultra Hypofractionation), which is not on this map. Cited by 62 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Partial Breast Re-irradiation Using Ultra Hypofractionation: Phase 2 Multi-institutional Study (PRESERVE)
Who cites it
62 citing papers in PubMed.
- Understanding breast cancer causes: insights from Jordanian women's awareness.Future science OA · 2026Article
- A deceptive fungating breast mass: giant fibroadenoma with multiple epidermal inclusion cysts mimicking malignancy.Future science OA · 2026Article
- Cost-effectiveness of mammography-based breast cancer screening in Jordan: a healthcare system perspective.Breast cancer (Tokyo, Japan) · 2026Article
- Diagnostic Performance and Geographic Variation in Mammography Services: A Nine-Year Audit from Southern Jordan.Diagnostics (Basel, Switzerland) · 2026Article
- Cost-effectiveness of organised versus opportunistic mammography breast cancer screening in low-resourced country.BMJ open · 2026Article
- Assessment of knowledge, awareness, perceptions, and attitudes toward breast reconstruction practice among medical students in Jordan: a cross-sectional study.BMC medical education · 2026Article
- Assessing the hepatic and renal parameters of breast cancer patient blood samples before and after chemotherapy.Toxicology reports · 2026Article
- Comprehensive genomic analysis of non-BRCA familial breast cancer in an Arab population.NPJ breast cancer · 2026Article
- Article
- An insight into the experience of healthcare providers and users of women-friendly health services in Jordan-a mixed method study.Frontiers in global women's health · 2026Article
- Elevated Serum Vitamin B12 Levels as a Potential Biomarker for Solid Tumors in Jordanian Patients: A Retrospective Case-Control Study.International journal of breast cancer · 2026Article
- A Simplified Novel Algorithm to Predict the 21-Gene Recurrence Score.World journal of oncology · 2025Article
- Uptake rate, barriers, and attitudes towards mammography screening for breast cancer in Jordan.Annals of medicine · 2025Article
- Pre-treatment red cell index and metastasis status as independent predictors of overall survival in Jordanian breast cancer patients receiving chemotherapy.Toxicology reports · 2025Article
- Knowledge and awareness of breast cancer signs and symptoms among Jordanian women.Future science OA · 2025Article
- The Therapeutic Potential ofMolecules (Basel, Switzerland) · 2025Article
- Knowledge, attitudes, and awareness of breast self-examination among female university students in three Arab countries: a multi-center cross-sectional study.BMC public health · 2025Article
- Knowledge and Beliefs Toward Mammography Screening Among Jordanian Women: Cross-Sectional Study.JMIR public health and surveillance · 2025Article
- Mutational spectrum and profile of breast and ovarian cancer patients in Saudi Arabia's western region: single center experience.Discover oncology · 2025Article
- Determinants and barriers to women's participation in breast cancer screening activities in Jordan: an in-depth study.BMC public health · 2025Article
2 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is the most common malignancy in Jordan and the third leading cause of cancer death after lung and colorectal cancers. Although the incidence of breast cancer in Jordan is lower than that in industrialized nations, the number of new cases has been significantly increasing, and women present with breast cancer at a younger age and with more advanced disease than women in Western countries. Jordan is a medium-income country with limited resources and a young population structure. Therefore, breast cancer poses a particularly challenging burden on the country's health care system. Despite ongoing endeavors to improve breast cancer care at both public and private levels, more work is needed to achieve downstaging of the disease and improve access, awareness, and participation in early detection. Multimodality treatment facilities and supportive care are available; however, the quality of care varies widely according to where the patient is treated, and most treatment facilities remain located centrally, thus, creating access difficulties. The King Hussein Cancer Center, the only comprehensive cancer center in Jordan, has changed the practice of oncology in the country via implementation of a multidisciplinary approach to treatment, monitoring of treatment outcomes, and investments in ongoing cancer research. However, there remains no national system for ensuring provision of high-quality cancer care nationwide. Here, we review the epidemiology of breast cancer and the current status of breast cancer care in Jordan, we compare our treatment outcomes with international ones, and we highlight challenges and improvement opportunities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.